STAT5 is critical to maintain effector CD8+ T cell responses

J Immunol. 2010 Aug 15;185(4):2116-24. doi: 10.4049/jimmunol.1000842. Epub 2010 Jul 19.

Abstract

During an immune response, most effector T cells die, whereas some are maintained and become memory T cells. Factors controlling the survival of effector CD4(+) and CD8(+) T cells remain unclear. In this study, we assessed the role of IL-7, IL-15, and their common signal transducer, STAT5, in maintaining effector CD4(+) and CD8(+) T cell responses. Following viral infection, IL-15 was required to maintain a subpopulation of effector CD8(+) T cells expressing high levels of killer cell lectin-like receptor subfamily G, member 1 (KLRG1), and lower levels of CD127, whereas IL-7 and IL-15 acted together to maintain KLRG1(low)CD127(high) CD8(+) effector T cells. In contrast, effector CD4(+) T cell numbers were not affected by the individual or combined loss of IL-15 and IL-7. Both IL-7 and IL-15 drove phosphorylation of STAT5 within effector CD4(+) and CD8(+) T cells. When STAT5 was deleted during the course of infection, both KLRG1(high)CD127(low) and KLRG1(low)CD127(high) CD8(+) T cells were lost, although effector CD4(+) T cell populations were maintained. Furthermore, STAT5 was required to maintain expression of Bcl-2 in effector CD8(+), but not CD4(+), T cells. Finally, IL-7 and IL-15 required STAT5 to induce Bcl-2 expression and to maintain effector CD8(+) T cells. Together, these data demonstrate that IL-7 and IL-15 signaling converge on STAT5 to maintain effector CD8(+) T cell responses.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • CD4-Positive T-Lymphocytes / immunology
  • CD4-Positive T-Lymphocytes / metabolism
  • CD8-Positive T-Lymphocytes / immunology*
  • CD8-Positive T-Lymphocytes / metabolism
  • Cell Line
  • Cell Survival / drug effects
  • Cell Survival / immunology
  • Cells, Cultured
  • Dose-Response Relationship, Drug
  • Female
  • Flow Cytometry
  • Interleukin-15 / genetics
  • Interleukin-15 / immunology
  • Interleukin-15 / pharmacology
  • Interleukin-2 Receptor beta Subunit / immunology
  • Interleukin-2 Receptor beta Subunit / metabolism
  • Interleukin-7 / immunology
  • Interleukin-7 / pharmacology
  • Interleukin-7 Receptor alpha Subunit / immunology
  • Interleukin-7 Receptor alpha Subunit / metabolism
  • Lymphocytic Choriomeningitis / immunology*
  • Lymphocytic Choriomeningitis / virology
  • Lymphocytic choriomeningitis virus / immunology*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Mice, Transgenic
  • Proto-Oncogene Proteins c-bcl-2 / genetics
  • Proto-Oncogene Proteins c-bcl-2 / immunology
  • Reverse Transcriptase Polymerase Chain Reaction
  • STAT5 Transcription Factor / genetics
  • STAT5 Transcription Factor / immunology*
  • Signal Transduction / immunology

Substances

  • Interleukin-15
  • Interleukin-2 Receptor beta Subunit
  • Interleukin-7
  • Interleukin-7 Receptor alpha Subunit
  • Proto-Oncogene Proteins c-bcl-2
  • STAT5 Transcription Factor